Stay updated on Inotuzumab Ozogamicin in B-ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin in B-ALL Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check11 days agoChange DetectedA site-wide NIH notice announces updates about a terminology transition, stating that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.3%

- Check18 days agoChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check25 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check46 days agoChange DetectedThe link label for locating contact information was updated from 'Find Contact Information' to 'Find contact information', and the site revision tag changed from v3.6.6 to v3.7.0.SummaryDifference0.1%

- Check68 days agoChange DetectedThe history shows additions of Contacts/Locations and Study Status, along with a new Revision: v3.6.6 dated 2026-08-25.SummaryDifference0.3%

Stay in the know with updates to Inotuzumab Ozogamicin in B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.